Background: Yersinia pestis, the causative agent of plague, is responsible for some of the greatest epidemic scourges of mankind. It is widespread in the western United States, although it has only been present there for just over 100 years. As a result, there has been very little time for diversity to accumulate in this region. Much of the diversity that has been detected among North American isolates is at loci that mutate too quickly to accurately reconstruct large-scale phylogenetic patterns. Slowly-evolving but stable markers such as SNPs could be useful for this purpose, but are difficult to identify due to the monomorphic nature of North American isolates.

Methodology/principal Findings: To identify SNPs that are polymorphic among North American populations of Y. pestis, a gapped genome sequence of Y. pestis strain FV-1 was generated. Sequence comparison of FV-1 with another North American strain, CO92, identified 19 new SNP loci that differ among North American isolates.

Conclusions/significance: The 19 SNP loci identified in this study should facilitate additional studies of the genetic population structure of Y. pestis across North America.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794153PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000220PLOS

Publication Analysis

Top Keywords

north american
24
yersinia pestis
8
genome sequence
8
snp loci
8
north
7
pestis
5
american
5
american yersinia
4
pestis draft
4
draft genome
4

Similar Publications

Focusing on the Yashkun population of Gilgit-Baltistan, an administrative territory in northern Pakistan, our study investigated mtDNA haplotypes as indicators of ancient gene flow and genetic diversity. Genomic DNA was extracted and evaluated for quality using agarose gel electrophoresis. The complete control region of mtDNA (nt 16024-576) was amplified via PCR, and sequencing was performed using the Big Dye Terminator Kit on an Applied Biosystems Genetic Analyzer.

View Article and Find Full Text PDF

Towards a histological diagnosis of childhood small vessel CNS vasculitis.

Pediatr Rheumatol Online J

December 2024

Section of Rheumatology, Department of Pediatrics, Alberta Children's Hospital, University of Calgary, Calgary, Canada.

Background: Primary small vessel CNS vasculitis (sv-cPACNS) is a challenging inflammatory brain disease in children. Brain biopsy is mandatory to confirm the diagnosis. This study aims to develop and validate a histological scoring tool for diagnosing small vessel CNS vasculitis.

View Article and Find Full Text PDF

FIGIJ and NASPAG Response to Dr. Grover's letter to the editor.

J Pediatr Adolesc Gynecol

December 2024

North American Society Pediatric Adolescent Gynecology, Division Director Pediatric Adolescent Gynecology, Department of Obstetrics, Gynecology and Reproductive Sciences, Courtesy Appointment Department of Pediatrics, 1120 NW 14th Street, Miami, Florida 33136. Electronic address:

View Article and Find Full Text PDF

Background: This paper reports on the outcomes of a proof-of-principle study for the Exposure Therapy Consortium, a global network of researchers and clinicians who work to improve the effectiveness and uptake of exposure therapy. The study aimed to test the feasibility of the consortium's big-team science approach and test the hypothesis that adding post-exposure processing focused on enhancing threat reappraisal would enhance the efficacy of a one-session large-group interoceptive exposure therapy protocol for reducing anxiety sensitivity.

Methods: The study involved a multi-site cluster-randomized controlled trial comparing exposure with post-processing (ENHANCED), exposure without post-processing (STANDARD), and a stress management intervention (CONTROL) in students with elevated anxiety sensitivity.

View Article and Find Full Text PDF

Progress on HIV and other sexually transmitted infections elimination among youth and adults across BRICS-plus countries: Results from the Global Burden of Disease Study 2021.

J Infect Public Health

December 2024

Department of Global Health, School of Public Health, Peking University, Beijing 100191, China; Institute for Global Health and Development, Peking University, Beijing 100191, China. Electronic address:

Background: Global strategies aim to eradicate HIV and other sexually transmitted infections (STIs) by 2030. We aim to assess HIV and other STIs morbidity trends from 1992 to 2021 across BRICS-plus (Brazil, Russia, India, China, South Africa, Egypt, Ethiopia, Iran, Saudi Arabia, and the United Arab Emirates), which accounts for nearly half of the world population.

Methods: HIV and other STIs morbidity estimates were derived from the Global Burden of Disease Study 2021.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!